These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6252172)

  • 1. Study of cefotaxime in the treatment of obstetric and gynaecological infections.
    Soutoul JH; Quentin R; Boscq G; Chazara C; Prieur D
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():283-5. PubMed ID: 6252172
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous cefoxitin sodium for the treatment of infections in obstetric and gynaecological patients.
    Galask RP; Ohm M
    J Antimicrob Chemother; 1978 Jul; 4(B):241-3. PubMed ID: 690024
    [No Abstract]   [Full Text] [Related]  

  • 3. The nonprophylactic role of cephalosporins in obstetrics and gynecology.
    LeFrock JL; Smith BR; Molavi A
    Bull N Y Acad Med; 1984 May; 60(4):416-25. PubMed ID: 6372917
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited-spectrum (first-generation) cephalosporins.
    Graham JM; Oshiro BT; Blanco JD
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):449-59. PubMed ID: 1436923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections in gynaecology and obstetrics and cefotaxime.
    Petersen EE
    Infection; 1989; 17(6):422-4. PubMed ID: 2613336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cephalosporins.
    Martens MG
    Obstet Gynecol Clin North Am; 1989 Jun; 16(2):291-304. PubMed ID: 2674797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
    White JS; Gee C; Ledger WJ
    J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience in the treatment of gynecologic and obstetrical infections with cefotaxime].
    Grcić R; Zivanović Z; Ivanović L; Stavrić V; Vucić V; Miscević L; Popović V; Prorocić M
    Med Pregl; 1985; 38(11-12):575-9. PubMed ID: 3835447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anaerobic gynecologic and obstetrical infections].
    Bygdeman M; Moberg PJ; Nord CE
    Lakartidningen; 1981 Mar; 78(13):1324-7. PubMed ID: 7218960
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with intravenous cefoxitin sodium in obstetrics and gynaecology.
    Sweet RL; Hadley KW; Mills J; Robbie M
    J Antimicrob Chemother; 1978 Jul; 4(B):249-50. PubMed ID: 357397
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical study of cefpirome sulphate in obstetric and gynaecological infections.
    Sagawa T; Fuiuno T; Sakuragi N; Kishida T; Yamada H; Fuiimoto S
    J Int Med Res; 2000; 28(6):288-99. PubMed ID: 11191722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical study of cefpimizole in obstetric and gynecologic infections.
    Sugiyama T; Miyahara K; Kato T
    Jpn J Antibiot; 1985 Apr; 38(4):1017-21. PubMed ID: 4032718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activities of telithromycin, a new ketolide, against bacteria causing infections in obstetric and gynaecological patients.
    Mikamo H; Hua YX; Sato Y; Hayasaki Y; Tamaya T
    J Antimicrob Chemother; 2000 Aug; 46(2):332-4. PubMed ID: 10933669
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulbactam/ampicillin versus cefotetan in the treatment of obstetric and gynecologic infections.
    Scalambrino S; Mangioni C; Milani R; Regallo M; Norchi S; Negri L; Carrera S; Vigano EF; Ruffilli MP; Canale MP
    Suppl Int J Gynecol Obstet; 1989; 2():21-7. PubMed ID: 2679680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic therapy of obstetric and gynecologic infections.
    Gorbach SL
    Surg Clin North Am; 1975 Dec; 55(6):1373-8. PubMed ID: 1198295
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro activity of S-1090, a novel oral cephalosporin, against bacteria causing infections in obstetric and gynaecological patients.
    Mikamo H; Kawazoe K; Sato Y; Izumi K; Tamaya T
    J Antimicrob Chemother; 1998 Jun; 41(6):664-5. PubMed ID: 9687109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies on cefpiramide in the field of obstetrics and gynecology].
    Tateno M; Kitagawa Y
    Jpn J Antibiot; 1985 Aug; 38(8):2367-73. PubMed ID: 4079010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical effects of meropenem on infectious diseases in obstetrics and gynecology].
    Chimura T; Murayama K; Oda T; Igarashi Y; Morisaki N; Hirayama T; Kihara K
    Jpn J Antibiot; 2001 Jan; 54(1):1-7. PubMed ID: 11268733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of expanded spectrum cephalosporins for the treatment of obstetrical and gynecological infections.
    Mercer LJ
    Obstet Gynecol Surv; 1988 Sep; 43(9):569-75. PubMed ID: 3145476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.